PIK3R1 underexpression is an independent prognostic marker in breast cancer

被引：0
|
作者：
Magdalena Cizkova
Sophie Vacher
Didier Meseure
Martine Trassard
Aurélie Susini
Dana Mlcuchova
Celine Callens
Etienne Rouleau
Frederique Spyratos
Rosette Lidereau
Ivan Bièche
机构：
[1] Hospital René Huguenin,Oncogenetic Laboratory, Institut Curie
[2] Palacky University and University Hospital Olomouc,Department of Oncology, Faculty of Medicine and Dentistry
[3] Palacky University and University Hospital Olomouc,Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry
[4] Hospital René Huguenin,Department of Pathology, Institut Curie
[5] Faculté des Sciences Pharmaceutiques et Biologiques,UMR745 INSERM, Université Paris Descartes, Sorbonne Paris Cité
[6] Institut Curie - Hôpital René Huguenin,Laboratoire d’Oncogénétique, 35 rue Dailly
来源：
BMC Cancer | / 13卷
关键词：
Breast cancer; Breast cancer subtypes; Signaling pathways; Prognostic value;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
    Ai, Xuejun
    Xiang, Lei
    Huang, Zhi
    Zhou, Shi
    Zhang, Shuai
    Zhang, Tao
    Jiang, Tianpeng
    BIOLOGICAL RESEARCH, 2018, 51
  • [32] High expression of PIK3R1 (p85α) correlates with poor survival in patients with metastatic breast cancer
    Yang, Yumei
    Li, Mei
    Li, Yanshuang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12797 - 12806
  • [33] RECK is not an independent prognostic marker for breast cancer
    Gomes, Luciana R.
    Fujita, Andre
    Mott, Joni D.
    Soares, Fernando A.
    Labriola, Leticia
    Sogayar, Mari C.
    BMC CANCER, 2015, 15
  • [34] RECK is not an independent prognostic marker for breast cancer
    Luciana R. Gomes
    André Fujita
    Joni D. Mott
    Fernando A. Soares
    Leticia Labriola
    Mari C. Sogayar
    BMC Cancer, 15
  • [35] BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma
    Sun, G. G.
    Wang, Y. D.
    Cheng, Y. J.
    Hu, W. N.
    TUMOR BIOLOGY, 2014, 35 (10) : 9707 - 9716
  • [36] Herb pair of Huangqi-Danggui exerts anti-tumor immunity to breast cancer by upregulating PIK3R1
    HaiXin Liu
    Li Lian
    LiLi Hou
    CaiXia Liu
    JinHong Ren
    YuanBiao Qiao
    ShiYuan Wen
    QingShan Li
    Animal Models and Experimental Medicine, 2024, 7 (03) : 234 - 258
  • [37] Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications
    Gupta, Ishita
    Gaykalova, Daria A.
    SEMINARS IN CANCER BIOLOGY, 2024, 106 : 58 - 86
  • [38] Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1
    Paoyun Tang
    Julia E. M. Upton
    Michelle A. Barton-Forbes
    Marina I. Salvadori
    Meghan P. Clynick
    April K. Price
    Sharan L. Goobie
    Journal of Clinical Immunology, 2018, 38 : 88 - 95
  • [39] PIK3CA and PIK3R1 mutations in cancer: from the mechanism of activation to PI3K targeted therapies
    Rzepecka, Iwona K.
    Tysarowski, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [40] Herb pair of Huangqi-Danggui exerts anti-tumor immunity to breast cancer by upregulating PIK3R1
    HaiXin Liu
    Li Lian
    LiLi Hou
    CaiXia Liu
    JinHong Ren
    YuanBiao Qiao
    ShiYuan Wen
    QingShan Li
    Animal Models and Experimental Medicine, 2024, (03) : 234 - 258
12345